Apadamtase alfa, recombinant Alternatives Compared
Apadamtase alfa, recombinant | Cablivi | Caplacizumab |
|
---|
Apadamtase alfa, recombinant | Cablivi (caplacizumab) | Caplacizumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Thrombotic Thrombocytopenic Purpura. apadamtase alfa, recombinant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Thrombotic Thrombocytopenic Purpura. Cablivi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Thrombotic Thrombocytopenic Purpura. caplacizumab may also be used for purposes not listed in this medication guide. |
Related suggestions Thrombotic Thrombocytopenic Purpura
|
|||||||
More about Apadamtase alfa, recombinant | More about Cablivi (caplacizumab) | More about Caplacizumab | ||||||||
Ratings & Reviews | ||||||||||
Apadamtase alfa, recombinant has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: apadamtase alfa, recombinant side effects in more detail. |
See also: Cablivi side effects in more detail. |
See also: caplacizumab side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cablivi prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Adzynma |
N/A |
Cablivi | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
47.8 hours |
N/A |
N/A |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 156 drugs are known to interact with Cablivi:
|
A total of 156 drugs are known to interact with caplacizumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
First Approval Date | ||||||||||
N/A |
February 06, 2019 |
February 06, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.